HLS Therapeutics Inc (HLS.TO)
3.66
+0.06
(+1.67%)
CAD |
TSX |
Sep 27, 16:00
HLS Therapeutics Debt to Equity Ratio: 0.9968 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.9968 |
March 31, 2024 | 0.9472 |
December 31, 2023 | 0.8878 |
September 30, 2023 | 0.8816 |
June 30, 2023 | 0.8356 |
March 31, 2023 | 0.7937 |
December 31, 2022 | 0.7687 |
September 30, 2022 | 0.7499 |
June 30, 2022 | 0.6264 |
March 31, 2022 | 0.5867 |
December 31, 2021 | 0.5981 |
September 30, 2021 | 0.6009 |
June 30, 2021 | 0.5994 |
March 31, 2021 | 0.6203 |
December 31, 2020 | 0.626 |
September 30, 2020 | 0.6398 |
June 30, 2020 | 0.5317 |
March 31, 2020 | 0.5366 |
December 31, 2019 | 0.5174 |
September 30, 2019 | 0.495 |
June 30, 2019 | 0.4893 |
March 31, 2019 | 0.609 |
December 31, 2018 | 0.6102 |
September 30, 2018 | 0.5862 |
June 30, 2018 | 0.6788 |
Date | Value |
---|---|
March 31, 2018 | 0.6882 |
December 31, 2017 | 0.7579 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.0008 |
June 30, 2012 | 0.0036 |
March 31, 2012 | 0.0067 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.495
Minimum
Sep 2019
0.9968
Maximum
Jun 2024
0.692
Average
0.6262
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 261.96M |
Total Liabilities (Quarterly) | 148.72M |
Shareholders Equity (Quarterly) | 113.24M |
Current Ratio | 2.024 |
Net Debt Paydown Yield | 2.76% |